Journal of Infectious Diseases and Medical Microbiology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Mini Review - Journal of Infectious Diseases and Medical Microbiology (2024) Volume 8, Issue 1

Antimicrobial resistance: A growing threat to public health

Raphael Keij *

Department of Health Policy and Management, York University, Canada

*Corresponding Author:
Raphael Keij
Department of Health Policy and Management, York University, Canada
E-mail: rakei2@yorku.ca

Received: 26-Dec-2023, Manuscript No. AAJIDMM-24-142950; Editor assigned: 29- Dec-2023, PreQC No. AAJIDMM-24-142950 (PQ); Reviewed:12-Jan-2024, QC No. AAJIDMM-24-142950; Revised: 16- Jan-2024, Manuscript No. AAJIDMM-24-142950; Published: 22- Jan-2024, DOI:10.35841/ aajidmm-8.1.186

Citation: : Keij Raphael. Antimicrobial resistance: A growing threat to public health. J Infect Dis Med Microbiol. 2024;8(1):186.

Introduction

Antimicrobial Resistance (AMR) stands as one of the most pressing challenges facing global public health in the 21st century. It refers to the ability of microorganisms—bacteria, viruses, fungi, and parasites—to resist the effects of antimicrobial agents, such as antibiotics, antivirals, antifungals, and antiparasitics, that were previously effective in treating infections. The emergence and spread of AMR threaten to undermine decades of progress in medicine and healthcare, making even routine infections potentially deadly and complicating the treatment of many diseases [1, 2].

Antimicrobial resistance develops naturally over time through genetic changes in microorganisms. However, the misuse and overuse of antimicrobial agents in humans, animals, and agriculture accelerate this process. Misuse includes inappropriate prescribing practices by healthcare providers, patient non-adherence to treatment regimens, and the widespread use of antibiotics in livestock and agriculture for growth promotion and disease prevention rather than treatment [3, 4].

The consequences of AMR are far-reaching. Infections that were once easily treatable with antibiotics can now become prolonged, more severe, and potentially life-threatening. This not only increases healthcare costs but also contributes to longer hospital stays, higher mortality rates, and significant societal and economic burdens [5, 6].

AMR affects people of all ages and socioeconomic backgrounds worldwide. In low- and middle-income countries, where infectious diseases are more prevalent and healthcare resources are limited, the impact of AMR is particularly profound. Treatments for common infections like pneumonia, tuberculosis, and urinary tract infections become less effective, leading to increased morbidity and mortality [7, 8].

By prioritizing antimicrobial stewardship, investing in research and development, and raising awareness among healthcare providers and the public, we can work towards a future where antimicrobials remain effective tools in combating infectious diseases. The time to act is now, to ensure that we protect the health of current and future generations against the growing threat of antimicrobial resistance [9, 10].

Conclusion

Antimicrobial resistance poses a significant threat to public health globally, jeopardizing our ability to effectively treat infections and undermining healthcare systems worldwide. Addressing AMR requires concerted efforts at local, national, and international levels, involving stakeholders from diverse sectors. While challenges persist, ongoing research, innovation, and collaboration offer hope for mitigating the impact of AMR and preserving the effectiveness of antimicrobial agents for future generations.

References

  1. Osset-Trénor P, Pascual-Ahuir A, Proft M. Fungal drug response and antimicrobial resistance. J Fungi (Basel). 2023;9(5):565.

    2. Indexed at, Google Scholar, Cross Ref

  2. Salam MA, Al-Amin MY, Salam MT, et al. Antimicrobial resistance: a growing serious threat for global public health. Healthcare (Basel). 2023;11(13): 1946.

    3. Indexed at, Google Scholar, Cross Ref

  3. Ferri M, Ranucci E, Romagnoli P, et al. Antimicrobial resistance: A global emerging threat to public health systems. Crit Rev Food Sci Nutr. 2017;57(13):2857-76.

    4. Indexed at, Google Scholar, Cross Ref

  4. Aslam B, Khurshid M, Arshad MI, et al. Antibiotic resistance: one health one world outlook. Front Cell Infect Microbiol. 2021;11:771510.

    5. Indexed at, Google Scholar, Cross Ref

  5. McClelland S, Lamoureux B, Larson E. Trends in antimicrobial resistance legislation 2011-2019: A review of the US policy response to the antimicrobial resistance threat and its public health Impact. Am J Infect Control. 2021;49(6):813-7.

    6. Indexed at, Google Scholar, Cross Ref

  6. Landrigan PJ, Stegeman JJ, Fleming LE, et al. Human health and ocean pollution. Ann Glob Health. 2020;86(1).

    7. Indexed at, Google Scholar, Cross Ref

  7. Lange C, Chesov D, Heyckendorf J, et al. Drug?resistant tuberculosis: an update on disease burden, diagnosis and treatment. 2018;23(7):656-73.

    8. Indexed at, Google Scholar, Cross Ref

  8. Nguyen AQ, Vu HP, Nguyen LN, et al. Monitoring antibiotic resistance genes in wastewater treatment: Current strategies and future challenges. Sci Total Environ. 2021;783:146964.

    9. Indexed at, Google Scholar, Cross Ref

  9. Sambaza SS, Naicker N. Contribution of wastewater to Antimicrobial Resistance-A Review article. J Glob Antimicrob Resist. 2023.

    10. Indexed at, Google Scholar, Cross Ref

  10. Aqib AI, Alsayeqh AF. Vancomycin drug resistance, an emerging threat to animal and public health. Front Vet Sci. 2022;9:1010728.

    11. Indexed at, Google Scholar, Cross Ref

Get the App